Smiles designed
in Switzerland.
Est. 2014, Solothurn. Built by orthodontists who were tired of waiting six weeks for parts that should take six days.
Founded out of frustration
In 2014, a group of practicing orthodontists in Solothurn grew weary of unpredictable import lead times, inconsistent quality, and minimum order quantities designed for procurement departments — not busy clinics. They decided to fix it themselves.
Nivellipso AG was incorporated that year with one goal: manufacture orthodontic supply of measurably better quality, sell it directly to practices, and ship within days — not weeks. The first production line was operational in Solothurn by early 2015, producing NiTi archwires and stainless-steel brackets.
Today Nivellipso employs 68 people in Solothurn and supplies over 1,412 practices across Switzerland, Germany, France, Austria, the Netherlands, and Scandinavia — all from a single 4,200 m² facility on the banks of the Aare.
In-house from raw material to shipment
Every product that leaves Solothurn is manufactured entirely in-house: from CNC-machined sapphire and stainless-steel brackets to thermoformed Helix clear aligners and drawn NiTi archwires. In-house manufacturing means we control every variable — alloy composition, force-deflection curves, bracket slot dimensions, aligner thickness.
- Helix Clear Aligners — produced from medical-grade PETG on our in-house thermoforming line. Each tray is digitally fabricated from patient STL files within 48 h of plan approval.
- Sapphire Brackets — single-crystal alumina brackets CNC-machined to ±5 µm tolerance. Lower friction coefficient than polycrystalline ceramic alternatives.
- NiTi & SS Archwires — drawn and heat-treated in-house. Shape-memory NiTi available in MBT, Roth, and custom-bend prescriptions.
- Vivera-style Retainers — fabricated from the same PETG stock as Helix aligners; same-week turnaround for registered practices.
Certified to the highest medical device standards
Our quality management system is independently audited annually. Device traceability is maintained from raw material batch to patient delivery. Post-market surveillance reports are filed quarterly with Swissmedic and notified to our EU notified body (BSI, CE 0123).